| Over a month ago |
|
Upgrade
|
UBS analyst Cody Ross… UBS analyst Cody Ross upgraded J.M. Smucker (SJM) to Neutral from Sell with a price target of $155, up from $132. The analyst cites the company's announcement that it will sell several pet food brands to Post Holdings (POST), the analyst tells investors in a research note. The firm adds that its prior Sell rating was predicated on the view that J.M. Smucker lacked the brand equity to keep pace with its categories' growth rate, but with the sale of half of its pet portfolio, the company is likely to deliver more consistent top-line growth in the future. ShowHide Related Items >><< - 02/08/23
- Post Holdings to acquire select pet food brands from J.M. Smucker for $1.2B
- 02/08/23
- J.M. Smucker to sell several pet food brands to Post Holdings for $1.2B
- 01/30/23
- Simply Good Foods says Geoff Tanner, named COO, CEO-elect of company
- 11/21/22
- J.M. Smucker CEO says 'organic top-line growth across all of our businesses'
- 02/02/23
- Post Holdings raises FY23 adjusted EBITDA view to $1.025B-$1.065B
- 11/22/22
- Post Holdings to exit ownership of BellRing Brands
- 02/09/23 Bernstein
- Bernstein ponders takeover targets for J.M. Smucker after pet food sale
- 12/20/22 Morgan Stanley
- J.M. Smucker upgraded to Equal Weight at Morgan Stanley on defensive positioning
- 12/20/22 Morgan Stanley
- J.M. Smucker upgraded to Equal Weight from Underweight at Morgan Stanley
- 12/15/22 Stifel
- J.M. Smucker price target raised to $155 from $148 at Stifel
- 02/07/23 Barclays
- Post Holdings price target raised to $105 from $102 at Barclays
- 02/06/23 Truist
- Post Holdings price target raised to $85 from $70 at Truist
- 01/06/23 Evercore ISI
- Hershey downgraded to In Line from Outperform at Evercore ISI
- 11/29/22 Piper Sandler
- Post Holdings price target raised to $115 from $107 at Piper Sandler
- 12/14/22
- J.M. Smucker backs FY23 adjusted EPS view $8.35 -$8.75, consensus $8.60
- 11/21/22
- J.M. Smucker raises FY23 adjusted EPS view to $8.35-$8.75 from $8.20-$8.60
- 11/21/22
- J.M. Smucker reports Q2 adjusted EPS $2.40, consensus $2.19
- 08/23/22
- J.M. Smucker raises FY23 adjusted EPS view to $8.20-$8.60 from $7.85-$8.25
- 02/02/23
- Post Holdings reports Q1 EPS $1.52, consensus 68c
- 11/17/22
- Post Holdings reports Q4 adjusted EPS 85c, consensus 70c
- 02/09/23
- What You Missed On Wall Street This Morning
- 12/20/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/21/22
- What You Missed On Wall Street On Monday
- 11/21/22
- What You Missed On Wall Street This Morning
- 02/09/23
- What You Missed On Wall Street On Thursday
|
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 01/31/23
- Exxon Mobil reports Q4 cash flow from operating activities $18.95B
- 01/30/23
- Exxon Mobil awards FEED for world's largest low-carbon hydrogen facility
- 01/24/23
- Exxon Mobil trading resumes
- 01/24/23
- Exxon Mobil trading halted, volatility trading pause
- 01/10/23
- Veru appoints David Ho as chairman of Scientific Advisory Board
- 11/09/22
- Veru announces update on FDA AdCom meeting on Sabizabulin as COVID treatment
- 11/09/22
- Veru trading halted, news pending
- 11/07/22
- Veru jumps 32% after FDA posts briefing documents for meeting of advisors
- 12/04/22
- Fly Intel: Top five weekend stock stories
- 09/09/22
- Tapestry announces long-term financial targets
- $20.80 /
+2.945 (+16.49%) - 11/16/22
- Sonos authorizes up to $100M stock buyback
- 11/16/22
- Sonos names Eddie Lazarus CFO
- 09/09/22
- USITC institutes investigation of Sonos audio players after Google complaint
- 08/10/22
- Sonos drops 20% to $18.18 after cutting FY22 guidance, CFO change
- 02/01/23
- Rapid7 trading resumes
- 02/01/23
- Rapid7 trading halted, volatility trading pause
- 09/22/22
- Rapid7 enters multi-year partnership with The Bruins
- 01/19/23
- Purple Innovation special committee comments on Capital Management filing
- 01/12/23
- Purple Innovation rejects unsolicited proposal from Coliseum Capital Management
- 12/15/22
- AWH Capital urges Purple Innovation to reject Coliseum's takeover offer
- 11/03/22
- Lovesac appoints John Legg as CSCO
- 02/08/23
- Post Holdings to acquire select pet food brands from J.M. Smucker for $1.2B
- 02/08/23
- J.M. Smucker to sell several pet food brands to Post Holdings for $1.2B
- 02/02/23
- Post Holdings raises FY23 adjusted EBITDA view to $1.025B-$1.065B
- 11/22/22
- Post Holdings to exit ownership of BellRing Brands
- 02/09/23
- PepsiCo sees FY23 share repurchases approximating $1B
- 02/09/23
- PepsiCo focused on delivering at least $1B in productivity savings
- 02/09/23
- PepsiCo: Monitoring consumers' spending patterns, behaviors
- 02/09/23
- PepsiCo expects inflationary pressures to persist
- 02/08/23
- New York Times sees Q1 subscription revenue up 6%-9%
- 12/12/22
- New York Times CFO Roland Caputo to retire
- 11/02/22
- New York Times sees Q4 subscription revenues up 17%-20%
- 08/11/22
- New York Times jumps after ValueAct discloses 6.7% active stake
- 02/09/23
- Globus Medical, NuVasive to combine in all-stock transaction
- 02/09/23
- Globus Medical, NuVasive to combine in all-stock transaction
- 12/19/22
- CubeSmart to replace NuVasive in S&P 400 at open on 12/19
- 12/19/22
- NuVasive to replace Tupperware Brands in S&P 600 at open on 12/19
- 11/07/22
- 23andMe presents poster for expansion chohorts for 23ME-00610
- 10/27/22
- 23andMe granted FDA 510(k) clearance for PGt report for SLCO1B1
- 09/19/22
- 23andMe appoints Daniel Chu as CPO
- 08/19/22
- 23andMe CFO Steven Schoch to step down
- 02/08/23
- Medtronic announces late-breaking clinical data from STROKE AF trial
- 01/30/23
- Medtronic recalls Hemodialysis Catheters for leaks, FDA says
- 01/27/23
- Orchestra BioMed begins trading on Nasdaq with cash runway into 2026
- 01/25/23
- Medtronic recommends rejection of below-market mini-tender by TRC Capital
- 02/08/23
- Mattel CEO: Our products are in demand and our business fundamentals are strong
- 02/08/23
- Mattel sees FY23 capex $175M-$200M vs. $187M in FY22
- 02/08/23
- Mattel says gross margins impacted by higher costs to manage inventory
- 02/08/23
- Mattel falls 10% to $18.50 after Q4 earnings miss, below-consensus guidance
- 02/06/23
- Southwest Dispatchers and Facilities Maintenance Technicians approve CBAs
- 02/01/23
- Southwest promotes Lauren Woods to chief information officer
- 01/26/23
- Southwest says it continues to experience year-over-year inflationary pressures
- 01/26/23
- Southwest plans to add 7,000 workers in 2023
- 02/09/23
- Kellogg sees FY23 tax rate 22%
- 02/09/23
- Kellogg working towards N.A. cereal spin-off, to retain plant-based business
- 02/09/23
- Kellogg CEO says entering 2023 in solid financial condition
- 01/30/23
- Colgate-Palmolive names Steve Cahillane to Board of Directors
- 12/05/22
- Hims & Hers names Scott Knoer as 1st Chief Pharmacy & Innovation Officer
- 11/15/22
- Amazon announces 'Amazon Clinic' virtual health service
- 11/08/22
- Hims & Hers rises 26.0%
- 11/08/22
- Hims & Hers rises 20.1%
- $62.98 /
-14.14 (-18.34%) - 02/09/23
- Globus Medical falls -17.3%
- 02/09/23
- Globus Medical falls -14.5%
- 02/09/23
- Globus Medical falls -14.9%
- 01/31/23
- Nevada reports December statewide gaming win up 14.3% to $1.31B
- 01/30/23
- Bragg Gaming launches new content with DraftKings in New Jersey
- 12/30/22
- DraftKings to launch online sportsbook in Ohio on New Year's Day
- 12/29/22
- Cathie Wood's ARK Investment bought 137K shares of DraftKings today
- $110.34 /
-1.435 (-1.28%) - 02/09/23
- Disney announces details of strategic restructuring
- 02/09/23
- Disney 'pleased' board can remain focused without proxy contest distraction
- 02/09/23
- Trian concludes proxy campaign with Disney, withdraws Peltz nomination
- 02/09/23
- Nelson Peltz says 'proxy fight is over' with Disney after last night's report
- 02/09/23
- DHT Holdings rises 13.5%
- 01/09/23
- DHT Holdings:Q4 time charter equivalent fleet earnings ~ $56,900 per day
- 09/08/22
- DHT Holdings announces new dividend policy
- 08/29/22
- DHT Holdings announces sale of DHT Edelweiss
CSII Cardiovascular Systems - 02/08/23
- Cardiovascular Systems trading resumes
- 02/08/23
- Cardiovascular Systems trading halted, news pending
- 02/09/23
- Credit Suisse announces acquisition of The Klein Group LLC for $175M
- 02/09/23
- Credit Suisse warns of 'substantial loss before taxes' for 2023
- 02/09/23
- Credit Suisse expects to report a loss for WM, IB in Q1
- 02/09/23
- Credit Suisse: Cost transformation 'well under way'
- 02/08/23
- Salesforce CEO teases AI efforts, says 'get ready to be wowed' by EinsteinGPT
- 01/27/23
- Salesforce appoints three new independent directors to board
- 01/22/23
- Fly Intel: Top five weekend stock stories
- 01/12/23
- Walmart enters partnership with Salesforce to provide solutions for retailers
- $12.33 /
-3.865 (-23.87%) - 10/05/22
- Digital Turbine announces investment in Aptoide app store
- $16.11 /
+3.425 (+27.00%) - 02/08/23
- AppLovin jumps 28% to $16.18 after Q4 results and guidance
- 11/30/22
- AppLovin exec sells $17.6M in common stock
- 11/29/22
- AppLovin CMO Jansen sells 48,562 class A shares
- 11/09/22
- AppLovin says 'uniquely positioned to emerge from downturn'
- 11/09/22
- Adidas sees 'strong' bottomline improvement in 2023
- 11/09/22
- Adidas sees FY22 currency-neutral revenue up at a low single digit rate
- 11/08/22
- Adidas names Bjorn Gulden as new CEO, effective January 1, 2023
- 11/04/22
- Adidas confirms talks with Gulden as potential successor to CEO
- 02/06/23
- Cathie Wood's ARK Investment bought 313.7K shares of Accolade today
- $108.06 /
-2.175 (-1.97%) - 02/08/23
- Cardiovascular Systems jumps 43% after announcing it is being acquired by Abbott
- 02/08/23
- Abbott to acquire Cardiovascular Systems for $20 per share, or $890M
- 01/26/23
- Abbott: FDA approves Proclaim XR spinal cord stimulation system
- 01/25/23
- Abbott expects $2B in covid testing in FY23
- 02/09/23
- AbbVie says 'high level of confidence' in achieving FY23 guidance
- 02/09/23
- AbbVie expects inflation to weigh on aesthetics business in 2023
- 02/09/23
- AbbVie says breadth, depth of pipeline supports long term growth outlook
- 02/09/23
- AbbVie reports Q4 global Humira net revenues $5.58B, up 4.6% on reported basis
- $150.95 /
-0.995 (-0.65%) - 02/02/23
- Apple pares decline during Q1 conference call, now down 1% at $149.35 afterhours
- 02/02/23
- Apple CFO says 'doing a lot of work on cost structure' to help gross margin
- 02/02/23
- Apple CFO says y/y performance of Q2 to be similar to Q1
- 02/02/23
- Apple CFO Maestri says customer satisfaction for iPhone 14 at 98%
- $110.34 /
-1.435 (-1.28%) - 02/09/23 Loop Capital
- Disney price target raised to $130 from $120 at Loop Capital
- 02/09/23 BofA
- Disney price target raised to $135 from $115 at BofA
- 02/09/23 KeyBanc
- Disney price target raised to $130 from $119 at KeyBanc
- 02/09/23 Credit Suisse
- Disney price target raised to $133 from $126 at Credit Suisse
- $108.06 /
-2.175 (-1.97%) - 02/09/23 Lake Street
- Cardiovascular Systems downgraded to Sell from Buy at Lake Street
- 02/07/23 Needham
- Surmodics price target lowered to $34 from $46 at Needham
- 01/27/23 Barclays
- Abbott price target raised to $125 from $122 at Barclays
- 01/26/23 Piper Sandler
- Abbott approval 'incremental headwind' to Nevro, says Piper Sandler
CSII Cardiovascular Systems - 12/21/22 Barclays
- Cardiovascular Systems initiated with an Equal Weight at Barclays
- 12/14/22 Lake Street
- Cardiovascular Systems initiated with a Buy at Lake Street
- 03/02/22 BofA
- Cardiovascular Systems reinstated with an Underperform at BofA
- 12/20/22 Atlantic Equities
- Coca-Cola, Pepsi remain preferred beverage names at Atlantic Equities
- 12/07/22 Argus
- PepsiCo price target raised to $206 from $195 at Argus
- 12/06/22 Deutsche Bank
- PepsiCo price target raised to $186 from $181 at Deutsche Bank
- 11/04/22 Redburn
- PepsiCo initiated with a Sell at Redburn
- 02/09/23 UBS
- J.M. Smucker upgraded to Neutral from Sell at UBS
- 02/07/23 Barclays
- Post Holdings price target raised to $105 from $102 at Barclays
- 02/06/23 Truist
- Post Holdings price target raised to $85 from $70 at Truist
- 01/06/23 Evercore ISI
- Hershey downgraded to In Line from Outperform at Evercore ISI
- 02/10/23 Wells Fargo
- Globus Medical downgraded to Equal Weight from Overweight at Wells Fargo
- 02/10/23 Wells Fargo
- NuVasive downgraded to Equal Weight from Overweight at Wells Fargo
- 02/10/23 Needham
- Needham downgrades Globus on 'meaningful' integration risks
- 02/10/23 Truist
- NuVasive downgraded to Hold from Buy at Truist
- $62.98 /
-14.14 (-18.34%) - 02/09/23 Roth MKM
- Roth MKM downgrades DraftKings to Sell with $15 price target
- 02/09/23 Roth MKM
- DraftKings downgraded to Sell from Neutral at Roth MKM
- 02/01/23 Piper Sandler
- DraftKings layoffs should be viewed positively, says Piper Sandler
- 01/23/23 Stifel
- DraftKings initiated with a Hold at Stifel
- 02/09/23 Jefferies
- Hims & Hers upgraded to Buy at Jefferies ahead of FY23 guidance
- 02/09/23 Jefferies
- Hims & Hers upgraded to Buy from Hold at Jefferies
- 01/10/23 Tigress Financial
- Hims & Hers price target raised to $12 from $11 at Tigress Financial
- 01/03/23 Piper Sandler
- Hims & Hers price target raised to $7 from $6 at Piper Sandler
- 02/09/23 Jefferies
- Accolade downgraded to Hold at Jefferies after 'lukewarm' survey results
- 02/09/23 Jefferies
- Accolade downgraded to Hold from Buy at Jefferies
- 02/02/23 Raymond James
- Accolade initiated with an Outperform at Raymond James
- 02/01/23 Raymond James
- Accolade initiated with an Outperform at Raymond James
- 02/09/23 Canaccord
- Rapid7 downgraded to Hold at Canaccord on 'soft' 2023 outlook
- 02/09/23 Mizuho
- Rapid7 price target raised to $45 from $40 at Mizuho
- 02/09/23 Baird
- Rapid7 price target lowered to $56 from $58 at Baird
- 02/09/23 Raymond James
- Rapid7 price target raised to $55 from $50 at Raymond James
- 02/09/23 Morgan Stanley
- New York Times price target raised to $40 from $37 at Morgan Stanley
- 02/09/23 Barclays
- New York Times upgraded to Equal Weight from Underweight at Barclays
- 12/16/22 Morgan Stanley
- New York Times downgraded to Equal Weight from Overweight at Morgan Stanley
- 08/11/22 Gordon Haskett
- New York Times share buys at UBS flagged by Gordon Haskett on activist link
- 02/01/23 Deutsche Bank
- Salesforce evaluating value options, shares have 35% upside, says Deutsche
- 01/30/23 Morgan Stanley
- Salesforce price target raised to $236 from $228 at Morgan Stanley
- 01/27/23 BMO Capital
- SAP price target raised to $125 from $110 at BMO Capital
- 01/23/23 Deutsche Bank
- Salesforce price target lowered to $190 from $200 at Deutsche Bank
- 02/08/23 Redburn
- Southwest downgraded to Neutral from Buy at Redburn
- 01/27/23 Deutsche Bank
- Southwest price target lowered to $52 from $56 at Deutsche Bank
- 01/27/23 TD Cowen
- Southwest price target lowered to $50 from $55 at Cowen
- 01/12/23 Barclays
- Southwest price target lowered to $42 from $48 at Barclays
- $150.95 /
-0.995 (-0.65%) - 02/07/23 Craig-Hallum
- Skyworks price target raised to $130 from $120 at Craig-Hallum
- 02/07/23 Credit Suisse
- Skyworks price target raised to $135 from $125 at Credit Suisse
- 02/07/23 KeyBanc
- Skyworks price target raised to $130 from $120 at KeyBanc
- 02/06/23 Credit Suisse
- Credit Suisse reiterates Outperform on Dell Technologies after 5% headcount cut
- 01/31/23 Bernstein
- Edwards Lifesciences downgraded to Underperform from Outperform at Bernstein
- 01/24/23 Mizuho
- Medtronic price target lowered to $95 from $100 at Mizuho
- 01/09/23 RBC Capital
- Medtronic downgraded to Sector Perform from Outperform at RBC Capital
- 11/30/22 Wells Fargo
- Medtronic price target lowered to $77 from $82 at Wells Fargo
- 02/02/23 Argus
- Exxon Mobil price target raised to $133 from $128 at Argus
- 02/02/23 TD Cowen
- Exxon Mobil price target raised to $113 from $108 at Cowen
- 02/01/23 Truist
- Exxon Mobil price target raised to $110 from $101 at Truist
- 02/01/23 BofA
- Exxon Mobil price target raised to $140 from $136 at BofA
- 01/27/23 Morgan Stanley
- Credit Suisse resumed with an Equal Weight at Morgan Stanley
- 01/13/23 Barclays
- Credit Suisse price target lowered to CHF 2.90 from CHF 4 at Barclays
- 01/13/23 Deutsche Bank
- Credit Suisse reinstated with a Hold at Deutsche Bank
- 12/20/22 Exane BNP Paribas
- Credit Suisse resumed with an Underperform at Exane BNP Paribas
- $16.11 /
+3.425 (+27.00%) - 02/09/23 Morgan Stanley
- AppLovin signs of stability 'count as a win,' says Morgan Stanley
- 02/08/23 Credit Suisse
- AppLovin price target lowered to $47 from $57 at Credit Suisse
- 02/06/23 KeyBanc
- AppLovin price target lowered to $20 from $25 at KeyBanc
- 01/27/23 DA Davidson
- Playtika cut to Neutral at DA Davidson on market share loss, Rovio offer
- $20.80 /
+2.945 (+16.49%) - 10/17/22 Morgan Stanley
- Sonos price target lowered to $17 from $20 at Morgan Stanley
- 08/11/22 Morgan Stanley
- Sonos price target lowered to $20 from $28 at Morgan Stanley
- 08/11/22 Stifel
- Sonos price target lowered to $20 from $24 at Stifel
- 06/14/22 Morgan Stanley
- Sonos downgraded to Equal Weight at Morgan Stanley amid inflation pressures
- 11/29/22 Jefferies
- DHT Holdings price target raised to $12 from $11 at Jefferies
- 07/20/22 Jefferies
- DHT Holdings initiated with a Buy at Jefferies
- 07/19/22 Stifel
- DHT Holdings price target raised to $8.50 from $7.50 at Stifel
- 04/27/22 Jefferies
- DHT Holdings reinstated with a Buy at Jefferies
- 11/28/22 Berenberg
- Berenberg starts 'well-positioned' 23andMe with a Buy
- 11/28/22 Berenberg
- 23andMe initiated with a Buy at Berenberg
- 09/22/22 TD Cowen
- 23andMe initiated with Outperform, $6 target at Cowen
- 09/22/22 TD Cowen
- 23andMe initiated with an Outperform at Cowen
- $12.33 /
-3.865 (-23.87%) - 02/09/23 Craig-Hallum
- Digital Turbine price target lowered to $25 from $30 at Craig-Hallum
- 02/09/23 Oppenheimer
- Oppenheimer downgrades Digital Turbine on 'unclear' long-term growth
- 02/09/23 Oppenheimer
- Digital Turbine downgraded to Perform from Outperform at Oppenheimer
- 02/01/23 B. Riley
- B. Riley downgrades Digital Turbine on app economy softness
- 02/10/23 H.C. Wainwright
- Veru price target lowered to $14 from $18 at H.C. Wainwright
- 12/07/22 H.C. Wainwright
- Veru price target lowered to $18 from $21 at H.C. Wainwright
- 11/10/22 H.C. Wainwright
- Veru price target lowered to $21 from $24 at H.C. Wainwright
- 09/20/22 Oppenheimer
- Oppenheimer optimism for Veru's sabizabulin EUA remains 'unchanged'
- 01/16/23 BofA
- Purple Innovation reinstated with an Underperform at BofA
- 11/10/22 Craig-Hallum
- Purple Innovation upgraded to Buy from Hold at Craig-Hallum
- 09/20/22 Craig-Hallum
- Purple Board likely to reject Coliseum's deal, says Craig-Hallum
- 09/20/22 Wedbush
- Purple Innovation price target raised to $5 from $3.30 at Wedbush
- 02/10/23 Morgan Stanley
- Tapestry assumed with an Equal Weight at Morgan Stanley
- 02/10/23 Baird
- Tapestry price target raised to $52 from $45 at Baird
- 01/23/23 Barclays
- Capri Holdings price target raised to $72 from $56 at Barclays
- 01/23/23 Barclays
- Tapestry downgraded to Equal Weight from Overweight at Barclays
- 02/10/23 SVB Securities
- AbbVie upgraded to Market Perform from Underperform at SVB Securities
- 02/10/23 SVB Securities
- AbbVie upgraded to Market Perform from Underperform at SVB Securities
- 02/09/23 Piper Sandler
- AbbVie price target raised to $163 from $157 at Piper Sandler
- 02/08/23 Truist
- Model N price target raised to $52 from $45 at Truist
- 01/30/23 Deutsche Bank
- Kellogg price target lowered to $72 from $74 at Deutsche Bank
- 12/20/22 Morgan Stanley
- Kellogg price target raised to $74 from $72 at Morgan Stanley
- 11/15/22 Exane BNP Paribas
- Kellogg initiated with an Underperform at Exane BNP Paribas
- 08/08/22 RBC Capital
- Kellogg price target raised to $70 from $66 at RBC Capital
- 02/10/23 BMO Capital
- Mattel price target lowered to $27 from $30 at BMO Capital
- 02/10/23 BofA
- Mattel price target lowered to $21 from $26 at BofA
- 02/09/23 DA Davidson
- Mattel price target lowered to $23 from $31 at DA Davidson
- 01/31/23 Goldman Sachs
- Mattel assumed with a Buy at Goldman Sachs
- 02/10/23 Jefferies
- Adidas downgraded to Hold from Buy at Jefferies
- 02/03/23 Deutsche Bank
- Adidas price target raised to EUR 170 from EUR 160 at Deutsche Bank
- 01/26/23 Credit Suisse
- Adidas price target raised to EUR 103 from EUR 83 at Credit Suisse
- 01/23/23 TD Cowen
- Skechers upgraded to Outperform at Cowen on momentum and margin recovery
- 01/31/23
- Exxon Mobil reports Q4 adjusted EPS $3.40, consensus $3.29
- 01/30/23
- Notable companies reporting before tomorrow's open
- 10/28/22
- Exxon Mobil reports Q3 adjusted EPS $4.45, consensus $3.79
- 02/09/23
- Veru reports Q1 EPS (46c), consensus (38c)
- 12/05/22
- Veru reports Q4 EPS (51c), consensus (30c)
- 08/11/22
- Veru reports Q3 EPS (28c), consensus (18c)
- 02/09/23
- Tapestry raises FY23 EPS view to $3.70-$3.75 from $3.60-$3.70, consensus $3.65
- 02/09/23
- Tapestry reports Q2 EPS $1.36, consensus $1.27
- $20.80 /
+2.945 (+16.49%) - 02/08/23
- Sonos affirms FY23 revenue view of $1.7B-$1.8B, consensus $1.73B
- 02/08/23
- Sonos reports Q1 EPS 79c, consensus 40c
- 11/16/22
- Sonos sees FY23 revenue $1.7B-$1.8B, consensus $1.72B
- 11/16/22
- Sonos reports Q4 adjusted EPS (32c), consensus (41c)
- 02/08/23
- Rapid7 guides initial FY23 EPS 81c-88c, consensus 49c
- 02/08/23
- Rapid7 sees Q1 EPS 7c-10c, consensus 7c
- 02/08/23
- Rapid7 reports Q4 EPS 35c, consensus 18c
- 11/02/22
- Rapid7 sees FY22 EPS 17c-20c, consensus 11c
- 01/30/23
- Purple Innovation sees FY22 net loss ($97.5M)-($83.7M)
- 11/09/22
- Purple Innovation backs FY22 revenue view $570M-$590M, consensus $578.66M
- 11/09/22
- Purple Innovation reports Q3 adjusted EPS 3c, consensus (5c)
- 02/02/23
- Post Holdings reports Q1 EPS $1.52, consensus 68c
- 11/17/22
- Post Holdings reports Q4 adjusted EPS 85c, consensus 70c
- 02/09/23
- PepsiCo sees FY23 core EPS $7.20, consensus $7.28
- 02/09/23
- PepsiCo sees FY23 core EPS growth 8%, consensus $7.28
- 02/09/23
- PepsiCo reports Q4 core EPS $1.67, consensus $1.65
- 02/08/23
- Notable companies reporting before tomorrow's open
- 02/08/23
- New York Times reports Q4 adjusted EPS 59c, consensus 43c
- 11/02/22
- New York Times reports Q3 adjusted EPS 21c, consensus 13c
- 02/09/23
- NuVasive sees FY23 net sales growth 6%-8%, consensus $1.28B
- 02/09/23
- NuVasive sees FY22 net sales growth 5.5%, consensus $1.21B
- 11/09/22
- NuVasive lowers FY22 non-GAAP EPS to $2.00-$2.10 from $2.15-$2.45
- 11/09/22
- NuVasive reports Q3 non-GAAP EPS 54c, consensus 54c
- 02/08/23
- 23andMe sees FY23 revenue $290M-$300M, consensus $276.59M
- 02/08/23
- 23andMe reports Q3 EPS (20c), consensus (19c)
- 11/07/22
- 23andMe sees FY23 revenue $260M-$280M, consensus $277.86M
- 11/07/22
- 23andMe reports Q2 EPS (15c), consensus (17c)
- 11/22/22
- Medtronic sees Q3 adjusted EPS $1.25-$1.27, consensus $1.40
- 11/22/22
- Medtronic says guidance assumes 2H23 reported revenue $15.4B-$15.6B
- 11/22/22
- Medtronic cuts FY23 EPS view to $5.25-$5.30 from $5.53-$5.65, consensus $5.53
- 11/22/22
- Medtronic reports Q2 EPS $1.30, consensus $1.28
- 02/08/23
- Mattel sees FY23 adjusted EPS $1.10-$1.20, consensus $1.66
- 02/08/23
- Mattel reports Q4 adjusted EPS 18c, consensus 29c
- 10/25/22
- Mattel cuts FY22 EPS view to $1.32-$1.42 from $1.42-$1.48
- 01/26/23
- Southwest sees Q1 revenue up 20%-24%, consensus $5.88B
- 01/26/23
- Southwest reports Q4 adjusted EPS (38c), consensus (9c)
- 01/25/23
- Notable companies reporting before tomorrow's open
- 02/09/23
- Kellogg sees FY23 EPS down 4% to down 2% on currency neutral basis
- 02/09/23
- Kellogg reports Q4 adjusted currency-neutral EPS 97c, consensus 84c
- 11/07/22
- Hims & Hers raises FY22 revenue view $519M-$522M from $470M-$485M
- 11/07/22
- Hims & Hers sees Q4 revenue $159M-$162M, consensus $134.3M
- 11/07/22
- Hims & Hers reports Q3 EPS (9c), consensus (10c)
- $62.98 /
-14.14 (-18.34%) - 02/09/23
- Globus Medical sees FY23 net sales growth 7%-8%, consensus $1.12B
- 02/09/23
- Globus Medical sees FY22 net sales growth 6.8%, consensus $1.03B
- 11/08/22
- Globus Medical sees FY22 EPS $2.03-$2.10, consensus $2.10
- 11/08/22
- Globus Medical reports Q3 EPS 50c, consensus 52c
- 11/04/22
- DraftKings sees 2023 revenue $2.8B-$3B, consensus $2.83B
- 11/04/22
- DraftKings raises 2022 revenue view $2.16B-$2.19B from $2.08B-$2.18B
- 11/04/22
- DraftKings reports Q3 revenue $502M, consensus $437.23M
- 11/03/22
- Notable companies reporting before tomorrow's open
- $110.34 /
-1.435 (-1.28%) - 02/08/23
- Disney reports Q1 EPS ex-items 99c, consensus 78c
- 02/08/23
- Notable companies reporting after market close
- 11/08/22
- Disney CFO sees FY23 cash content spend in low-$30B range
- 11/08/22
- Disney reports Q4 EPS ex-items 30c, consensus 57c
- 02/08/23
- DHT Holdings reports Q4 EPS 38c, consensus 30c
- 11/07/22
- DHT Holdings reports Q3 EPS 4c, consensus (1c)
- 08/10/22
- DHT Holdings reports Q2 EPS 6c, consensus (4c)
CSII Cardiovascular Systems - 02/08/23
- Cardiovascular Systems reports Q2 EPS (20c), consensus (15c)
- 11/03/22
- Cardiovascular Systems sees FY22 revenue $255M-$265M, consensus $258.48M
- 11/03/22
- Cardiovascular Systems reports Q1 EPS (27c), consensus (23c)
- 02/09/23
- Credit Suisse reports Q4 net revenue CHF 3.06B vs. CHF 4.58B last year
- 10/27/22
- Credit Suisse reports Q3 net revenue CHF 3.8B vs. CHF 5.43B last year
- 11/30/22
- Salesforce raises FY23 EPS view to $4.92-$4.94, consensus $4.73
- 11/30/22
- Salesforce sees Q4 EPS $1.35-$1.37, consensus $1.34
- 11/30/22
- Salesforce reports Q3 EPS $1.40, consensus $1.21
- 11/30/22
- Notable companies reporting after market close
- $12.33 /
-3.865 (-23.87%) - 02/08/23
- Digital Turbine sees FY23 adjusted EPS $1.15-$1.20, consensus $1.41
- 02/08/23
- Digital Turbine reports Q3 adjusted EPS 29c, consensus 37c
- 11/09/22
- Digital Turbine sees Q3 adjusted EPS 36c-39c, consensus 38c
- 11/09/22
- Digital Turbine reports Q2 non-GAAP EPS 34c, consensus 33c
- $16.11 /
+3.425 (+27.00%) - 02/08/23
- AppLovin sees Q1 revenue $685M-$705M, consensus $682.2M
- 02/08/23
- AppLovin reports Q4 adjusted EBITDA up 17% at $260M
- 11/09/22
- AppLovin cuts FY22 revenue view from $2.84B-$3.14B to $2.80B-$2.81B
- 02/09/23
- Adidas reports preliminary 2022 sales up 1% in currency-neutral terms
- 02/09/23
- Adidas sees 2023 currency-neutral sales down high-single-digits
- 11/09/22
- Adidas reports Q3 revenue EUR 6.41B vs. EUR 5.752B last year
- 10/20/22
- Adidas now expects FY22 currency neutral revenue up at mid single digit rate
- 01/09/23
- Accolade guides initial FY24 revenue around $410M, consensus $405.4M
- 01/09/23
- Accolade narrows FY23 revenue view to $361M-$365M, consensus $359.2M
- 01/09/23
- Accolade sees Q4 revenue $97M-$101M, consensus $101.7M
- 01/09/23
- Accolade reports Q3 EPS (56c), consensus (62c)
- $108.06 /
-2.175 (-1.97%) - 01/25/23
- Abbott sees FY23 adjusted EPS $4.30-$4.50, consensus $4.40
- 01/25/23
- Abbott reports Q4 adjusted EPS $1.03, consensus 92c
- 01/24/23
- Notable companies reporting before tomorrow's open
- 02/09/23
- AbbVie sees Q1 adjusted EPS $2.39-$2.49, consensus $3.08
- 02/09/23
- AbbVie sees FY23 revenue about $52B, consensus $54.21B
- 02/09/23
- AbbVie sees FY23 adjusted EPS $10.70-$11.10, consensus $11.65
- 02/09/23
- AbbVie reports Q4 adjusted EPS $3.60, consensus $3.56
- $150.95 /
-0.995 (-0.65%) - 02/02/23
- Apple reports Q1 EPS $1.88, consensus $1.94
- 02/02/23
- Notable companies reporting after market close
- 10/27/22
- Apple reports Q4 EPS $1.29, consensus $1.17
- 10/27/22
- Notable companies reporting after market close
|
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 01/31/23
- Exxon Mobil reports Q4 cash flow from operating activities $18.95B
- 01/30/23
- Exxon Mobil awards FEED for world's largest low-carbon hydrogen facility
- 01/24/23
- Exxon Mobil trading resumes
- 01/24/23
- Exxon Mobil trading halted, volatility trading pause
- 01/10/23
- Veru appoints David Ho as chairman of Scientific Advisory Board
- 11/09/22
- Veru announces update on FDA AdCom meeting on Sabizabulin as COVID treatment
- 11/09/22
- Veru trading halted, news pending
- 11/07/22
- Veru jumps 32% after FDA posts briefing documents for meeting of advisors
- 12/04/22
- Fly Intel: Top five weekend stock stories
- 09/09/22
- Tapestry announces long-term financial targets
- $21.04 /
+3.185 (+17.84%) - 11/16/22
- Sonos authorizes up to $100M stock buyback
- 11/16/22
- Sonos names Eddie Lazarus CFO
- 09/09/22
- USITC institutes investigation of Sonos audio players after Google complaint
- 08/10/22
- Sonos drops 20% to $18.18 after cutting FY22 guidance, CFO change
- 01/30/23
- Simply Good Foods says Geoff Tanner, named COO, CEO-elect of company
- 11/21/22
- J.M. Smucker CEO says 'organic top-line growth across all of our businesses'
- 02/01/23
- Rapid7 trading resumes
- 02/01/23
- Rapid7 trading halted, volatility trading pause
- 09/22/22
- Rapid7 enters multi-year partnership with The Bruins
- 01/19/23
- Purple Innovation special committee comments on Capital Management filing
- 01/12/23
- Purple Innovation rejects unsolicited proposal from Coliseum Capital Management
- 12/15/22
- AWH Capital urges Purple Innovation to reject Coliseum's takeover offer
- 11/03/22
- Lovesac appoints John Legg as CSCO
- 02/08/23
- Post Holdings to acquire select pet food brands from J.M. Smucker for $1.2B
- 02/08/23
- J.M. Smucker to sell several pet food brands to Post Holdings for $1.2B
- 02/02/23
- Post Holdings raises FY23 adjusted EBITDA view to $1.025B-$1.065B
- 11/22/22
- Post Holdings to exit ownership of BellRing Brands
- 02/09/23
- PepsiCo sees FY23 share repurchases approximating $1B
- 02/09/23
- PepsiCo focused on delivering at least $1B in productivity savings
- 02/09/23
- PepsiCo: Monitoring consumers' spending patterns, behaviors
- 02/09/23
- PepsiCo expects inflationary pressures to persist
- 02/08/23
- New York Times sees Q1 subscription revenue up 6%-9%
- 12/12/22
- New York Times CFO Roland Caputo to retire
- 11/02/22
- New York Times sees Q4 subscription revenues up 17%-20%
- 08/11/22
- New York Times jumps after ValueAct discloses 6.7% active stake
- 02/09/23
- Globus Medical, NuVasive to combine in all-stock transaction
- 02/09/23
- Globus Medical, NuVasive to combine in all-stock transaction
- 12/19/22
- CubeSmart to replace NuVasive in S&P 400 at open on 12/19
- 12/19/22
- NuVasive to replace Tupperware Brands in S&P 600 at open on 12/19
- 11/07/22
- 23andMe presents poster for expansion chohorts for 23ME-00610
- 10/27/22
- 23andMe granted FDA 510(k) clearance for PGt report for SLCO1B1
- 09/19/22
- 23andMe appoints Daniel Chu as CPO
- 08/19/22
- 23andMe CFO Steven Schoch to step down
- 02/08/23
- Medtronic announces late-breaking clinical data from STROKE AF trial
- 01/30/23
- Medtronic recalls Hemodialysis Catheters for leaks, FDA says
- 01/27/23
- Orchestra BioMed begins trading on Nasdaq with cash runway into 2026
- 01/25/23
- Medtronic recommends rejection of below-market mini-tender by TRC Capital
- $18.42 /
-2.065 (-10.08%) - 02/08/23
- Mattel CEO: Our products are in demand and our business fundamentals are strong
- 02/08/23
- Mattel sees FY23 capex $175M-$200M vs. $187M in FY22
- 02/08/23
- Mattel says gross margins impacted by higher costs to manage inventory
- 02/08/23
- Mattel falls 10% to $18.50 after Q4 earnings miss, below-consensus guidance
- 02/06/23
- Southwest Dispatchers and Facilities Maintenance Technicians approve CBAs
- 02/01/23
- Southwest promotes Lauren Woods to chief information officer
- 01/26/23
- Southwest says it continues to experience year-over-year inflationary pressures
- 01/26/23
- Southwest plans to add 7,000 workers in 2023
- 02/09/23
- Kellogg sees FY23 tax rate 22%
- 02/09/23
- Kellogg working towards N.A. cereal spin-off, to retain plant-based business
- 02/09/23
- Kellogg CEO says entering 2023 in solid financial condition
- 01/30/23
- Colgate-Palmolive names Steve Cahillane to Board of Directors
- 12/05/22
- Hims & Hers names Scott Knoer as 1st Chief Pharmacy & Innovation Officer
- 11/15/22
- Amazon announces 'Amazon Clinic' virtual health service
- 11/08/22
- Hims & Hers rises 26.0%
- 11/08/22
- Hims & Hers rises 20.1%
- $63.41 /
-13.71 (-17.78%) - 02/09/23
- Globus Medical falls -17.3%
- 02/09/23
- Globus Medical falls -14.5%
- 02/09/23
- Globus Medical falls -14.9%
- 01/31/23
- Nevada reports December statewide gaming win up 14.3% to $1.31B
- 01/30/23
- Bragg Gaming launches new content with DraftKings in New Jersey
- 12/30/22
- DraftKings to launch online sportsbook in Ohio on New Year's Day
- 12/29/22
- Cathie Wood's ARK Investment bought 137K shares of DraftKings today
- $113.43 /
+1.655 (+1.48%) - 02/09/23
- Trian concludes proxy campaign with Disney, withdraws Peltz nomination
- 02/09/23
- Nelson Peltz says 'proxy fight is over' with Disney after last night's report
- 02/09/23
- Disney's Iger to CNBC: Board work on sucecssor 'already underway'
- 02/09/23
- Disney CEO Iger: 'My preference' is to stay for two years
- $10.25 /
+1.105 (+12.08%) - 02/09/23
- DHT Holdings rises 13.5%
- 01/09/23
- DHT Holdings:Q4 time charter equivalent fleet earnings ~ $56,900 per day
- 09/08/22
- DHT Holdings announces new dividend policy
- 08/29/22
- DHT Holdings announces sale of DHT Edelweiss
CSII Cardiovascular Systems - 02/08/23
- Cardiovascular Systems trading resumes
- 02/08/23
- Cardiovascular Systems trading halted, news pending
- 02/08/23
- Salesforce CEO teases AI efforts, says 'get ready to be wowed' by EinsteinGPT
- 01/27/23
- Salesforce appoints three new independent directors to board
- 01/22/23
- Fly Intel: Top five weekend stock stories
- 01/12/23
- Walmart enters partnership with Salesforce to provide solutions for retailers
- 02/07/23
- AstraZeneca's Forxiga approved in E.U. for treatment of chronic heart failure
- 02/02/23
- Amgen's Tezspire approved in U.S. for self-administration in severe asthma
- 01/26/23
- AstraZeneca continuing to work with FDA to collect data on Evusheld and variants
- 01/26/23
- FDA announces Evusheld not currently authorized for emergency use in U.S.
- 10/05/22
- Digital Turbine announces investment in Aptoide app store
- $16.31 /
+3.625 (+28.58%) - 02/08/23
- AppLovin jumps 28% to $16.18 after Q4 results and guidance
- 11/30/22
- AppLovin exec sells $17.6M in common stock
- 11/29/22
- AppLovin CMO Jansen sells 48,562 class A shares
- 11/09/22
- AppLovin says 'uniquely positioned to emerge from downturn'
- 02/06/23
- Cathie Wood's ARK Investment bought 313.7K shares of Accolade today
- $109.77 /
-0.465 (-0.42%) - 02/08/23
- Cardiovascular Systems jumps 43% after announcing it is being acquired by Abbott
- 02/08/23
- Abbott to acquire Cardiovascular Systems for $20 per share, or $890M
- 01/26/23
- Abbott: FDA approves Proclaim XR spinal cord stimulation system
- 01/25/23
- Abbott expects $2B in covid testing in FY23
- 02/09/23
- AbbVie says 'high level of confidence' in achieving FY23 guidance
- 02/09/23
- AbbVie expects inflation to weigh on aesthetics business in 2023
- 02/09/23
- AbbVie says breadth, depth of pipeline supports long term growth outlook
- 02/09/23
- AbbVie reports Q4 global Humira net revenues $5.58B, up 4.6% on reported basis
- 01/11/23
- AllianceBernstein reports preliminary AUM $646B as of December 31, 2022
- 12/12/22
- AllianceBernstein reports preliminary AUM $658B as of November 30
- 11/30/22
- Janus Henderson names Michelle Dunstan Chief Responsibility Officer
- 11/22/22
- AllianceBernstein, Societe Generale to form cash equities JV
- $153.00 /
+1.055 (+0.69%) - 02/02/23
- Apple pares decline during Q1 conference call, now down 1% at $149.35 afterhours
- 02/02/23
- Apple CFO says 'doing a lot of work on cost structure' to help gross margin
- 02/02/23
- Apple CFO says y/y performance of Q2 to be similar to Q1
- 02/02/23
- Apple CFO Maestri says customer satisfaction for iPhone 14 at 98%
- $153.00 /
+1.055 (+0.69%) - 02/07/23 Craig-Hallum
- Skyworks price target raised to $130 from $120 at Craig-Hallum
- 02/07/23 Credit Suisse
- Skyworks price target raised to $135 from $125 at Credit Suisse
- 02/07/23 KeyBanc
- Skyworks price target raised to $130 from $120 at KeyBanc
- 02/06/23 Credit Suisse
- Credit Suisse reiterates Outperform on Dell Technologies after 5% headcount cut
- 01/31/23 Bernstein
- Edwards Lifesciences downgraded to Underperform from Outperform at Bernstein
- 01/24/23 Mizuho
- Medtronic price target lowered to $95 from $100 at Mizuho
- 01/09/23 RBC Capital
- Medtronic downgraded to Sector Perform from Outperform at RBC Capital
- 11/30/22 Wells Fargo
- Medtronic price target lowered to $77 from $82 at Wells Fargo
- $113.43 /
+1.655 (+1.48%) - 02/09/23 Loop Capital
- Disney price target raised to $130 from $120 at Loop Capital
- 02/09/23 BofA
- Disney price target raised to $135 from $115 at BofA
- 02/09/23 KeyBanc
- Disney price target raised to $130 from $119 at KeyBanc
- 02/09/23 Credit Suisse
- Disney price target raised to $133 from $126 at Credit Suisse
- $109.77 /
-0.465 (-0.42%) - 02/09/23 Lake Street
- Cardiovascular Systems downgraded to Sell from Buy at Lake Street
- 02/07/23 Needham
- Surmodics price target lowered to $34 from $46 at Needham
- 01/27/23 Barclays
- Abbott price target raised to $125 from $122 at Barclays
- 01/26/23 Piper Sandler
- Abbott approval 'incremental headwind' to Nevro, says Piper Sandler
CSII Cardiovascular Systems - 12/21/22 Barclays
- Cardiovascular Systems initiated with an Equal Weight at Barclays
- 12/14/22 Lake Street
- Cardiovascular Systems initiated with a Buy at Lake Street
- 03/02/22 BofA
- Cardiovascular Systems reinstated with an Underperform at BofA
- 12/20/22 Atlantic Equities
- Coca-Cola, Pepsi remain preferred beverage names at Atlantic Equities
- 12/07/22 Argus
- PepsiCo price target raised to $206 from $195 at Argus
- 12/06/22 Deutsche Bank
- PepsiCo price target raised to $186 from $181 at Deutsche Bank
- 11/04/22 Redburn
- PepsiCo initiated with a Sell at Redburn
- 02/07/23 Barclays
- Post Holdings price target raised to $105 from $102 at Barclays
- 02/06/23 Truist
- Post Holdings price target raised to $85 from $70 at Truist
- 01/06/23 Evercore ISI
- Hershey downgraded to In Line from Outperform at Evercore ISI
- 11/29/22 Piper Sandler
- Post Holdings price target raised to $115 from $107 at Piper Sandler
- 02/09/23 Bernstein
- Bernstein ponders takeover targets for J.M. Smucker after pet food sale
- 12/20/22 Morgan Stanley
- J.M. Smucker upgraded to Equal Weight at Morgan Stanley on defensive positioning
- 12/20/22 Morgan Stanley
- J.M. Smucker upgraded to Equal Weight from Underweight at Morgan Stanley
- 12/15/22 Stifel
- J.M. Smucker price target raised to $155 from $148 at Stifel
- 02/09/23 Piper Sandler
- Piper downgrades NuVasive, Globus on merger agreement
- 02/09/23 Piper Sandler
- NuVasive downgraded to Neutral from Overweight at Piper Sandler
- 01/06/23 Needham
- NuVasive downgraded to Hold from Buy at Needham
- 11/10/22 TD Cowen
- NuVasive price target lowered to $50 from $65 at Cowen
- $63.41 /
-13.71 (-17.78%) - 02/09/23 Piper Sandler
- Globus Medical downgraded to Neutral from Overweight at Piper Sandler
- 01/04/23 Barclays
- Globus Medical price target raised to $82 from $70 at Barclays
- 10/18/22 Barclays
- Barclays starts medical devices with Positive view, Boston Scientific top pick
- 02/09/23 Roth MKM
- Roth MKM downgrades DraftKings to Sell with $15 price target
- 02/09/23 Roth MKM
- DraftKings downgraded to Sell from Neutral at Roth MKM
- 02/01/23 Piper Sandler
- DraftKings layoffs should be viewed positively, says Piper Sandler
- 01/23/23 Stifel
- DraftKings initiated with a Hold at Stifel
- 02/09/23 Jefferies
- Hims & Hers upgraded to Buy at Jefferies ahead of FY23 guidance
- 02/09/23 Jefferies
- Hims & Hers upgraded to Buy from Hold at Jefferies
- 01/10/23 Tigress Financial
- Hims & Hers price target raised to $12 from $11 at Tigress Financial
- 01/03/23 Piper Sandler
- Hims & Hers price target raised to $7 from $6 at Piper Sandler
- 02/09/23 Jefferies
- Accolade downgraded to Hold at Jefferies after 'lukewarm' survey results
- 02/09/23 Jefferies
- Accolade downgraded to Hold from Buy at Jefferies
- 02/02/23 Raymond James
- Accolade initiated with an Outperform at Raymond James
- 02/01/23 Raymond James
- Accolade initiated with an Outperform at Raymond James
- 02/09/23 Canaccord
- Rapid7 downgraded to Hold at Canaccord on 'soft' 2023 outlook
- 02/09/23 Mizuho
- Rapid7 price target raised to $45 from $40 at Mizuho
- 02/09/23 Baird
- Rapid7 price target lowered to $56 from $58 at Baird
- 02/09/23 Raymond James
- Rapid7 price target raised to $55 from $50 at Raymond James
- 02/09/23 Morgan Stanley
- New York Times price target raised to $40 from $37 at Morgan Stanley
- 02/09/23 Barclays
- New York Times upgraded to Equal Weight from Underweight at Barclays
- 12/16/22 Morgan Stanley
- New York Times downgraded to Equal Weight from Overweight at Morgan Stanley
- 08/11/22 Gordon Haskett
- New York Times share buys at UBS flagged by Gordon Haskett on activist link
- 02/01/23 Deutsche Bank
- Salesforce evaluating value options, shares have 35% upside, says Deutsche
- 01/30/23 Morgan Stanley
- Salesforce price target raised to $236 from $228 at Morgan Stanley
- 01/27/23 BMO Capital
- SAP price target raised to $125 from $110 at BMO Capital
- 01/23/23 Deutsche Bank
- Salesforce price target lowered to $190 from $200 at Deutsche Bank
- 02/08/23 Redburn
- Southwest downgraded to Neutral from Buy at Redburn
- 01/27/23 Deutsche Bank
- Southwest price target lowered to $52 from $56 at Deutsche Bank
- 01/27/23 TD Cowen
- Southwest price target lowered to $50 from $55 at Cowen
- 01/12/23 Barclays
- Southwest price target lowered to $42 from $48 at Barclays
- 02/02/23 Argus
- Exxon Mobil price target raised to $133 from $128 at Argus
- 02/02/23 TD Cowen
- Exxon Mobil price target raised to $113 from $108 at Cowen
- 02/01/23 Truist
- Exxon Mobil price target raised to $110 from $101 at Truist
- 02/01/23 BofA
- Exxon Mobil price target raised to $140 from $136 at BofA
- 02/07/23 Evercore ISI
- AllianceBernstein added to 'Tactical Outperform' list at Evercore ISI
- 10/18/22 Credit Suisse
- AllianceBernstein initiated with a Neutral at Credit Suisse
- 09/07/22 BofA
- AllianceBernstein reinstated with a Neutral at BofA
- 09/07/22 BofA
- AllianceBernstein reinstated with a Neutral at BofA
- $16.31 /
+3.625 (+28.58%) - 02/09/23 Morgan Stanley
- AppLovin signs of stability 'count as a win,' says Morgan Stanley
- 02/08/23 Credit Suisse
- AppLovin price target lowered to $47 from $57 at Credit Suisse
- 02/06/23 KeyBanc
- AppLovin price target lowered to $20 from $25 at KeyBanc
- 01/27/23 DA Davidson
- Playtika cut to Neutral at DA Davidson on market share loss, Rovio offer
- $21.04 /
+3.185 (+17.84%) - 10/17/22 Morgan Stanley
- Sonos price target lowered to $17 from $20 at Morgan Stanley
- 08/11/22 Morgan Stanley
- Sonos price target lowered to $20 from $28 at Morgan Stanley
- 08/11/22 Stifel
- Sonos price target lowered to $20 from $24 at Stifel
- 06/14/22 Morgan Stanley
- Sonos downgraded to Equal Weight at Morgan Stanley amid inflation pressures
- $10.25 /
+1.105 (+12.08%) - 11/29/22 Jefferies
- DHT Holdings price target raised to $12 from $11 at Jefferies
- 07/20/22 Jefferies
- DHT Holdings initiated with a Buy at Jefferies
- 07/19/22 Stifel
- DHT Holdings price target raised to $8.50 from $7.50 at Stifel
- 04/27/22 Jefferies
- DHT Holdings reinstated with a Buy at Jefferies
- 11/28/22 Berenberg
- Berenberg starts 'well-positioned' 23andMe with a Buy
- 11/28/22 Berenberg
- 23andMe initiated with a Buy at Berenberg
- 09/22/22 TD Cowen
- 23andMe initiated with Outperform, $6 target at Cowen
- 09/22/22 TD Cowen
- 23andMe initiated with an Outperform at Cowen
- 02/09/23 Craig-Hallum
- Digital Turbine price target lowered to $25 from $30 at Craig-Hallum
- 02/09/23 Oppenheimer
- Oppenheimer downgrades Digital Turbine on 'unclear' long-term growth
- 02/09/23 Oppenheimer
- Digital Turbine downgraded to Perform from Outperform at Oppenheimer
- 02/01/23 B. Riley
- B. Riley downgrades Digital Turbine on app economy softness
- 12/07/22 H.C. Wainwright
- Veru price target lowered to $18 from $21 at H.C. Wainwright
- 11/10/22 H.C. Wainwright
- Veru price target lowered to $21 from $24 at H.C. Wainwright
- 09/20/22 Oppenheimer
- Oppenheimer optimism for Veru's sabizabulin EUA remains 'unchanged'
- 09/08/22 Oppenheimer
- Oppenheimer remains bullish on Veru, optimism for EUA unchanged
- 01/16/23 BofA
- Purple Innovation reinstated with an Underperform at BofA
- 11/10/22 Craig-Hallum
- Purple Innovation upgraded to Buy from Hold at Craig-Hallum
- 09/20/22 Craig-Hallum
- Purple Board likely to reject Coliseum's deal, says Craig-Hallum
- 09/20/22 Wedbush
- Purple Innovation price target raised to $5 from $3.30 at Wedbush
- 01/23/23 Barclays
- Capri Holdings price target raised to $72 from $56 at Barclays
- 01/23/23 Barclays
- Tapestry downgraded to Equal Weight from Overweight at Barclays
- 12/20/22 Raymond James
- Tapestry initiated with an Outperform at Raymond James
- 12/19/22 Raymond James
- Tapestry initiated with an Outperform at Raymond James
- 02/08/23 Truist
- Model N price target raised to $52 from $45 at Truist
- 01/26/23 JPMorgan
- AbbVie recent weakness a buying opportunity, says JPMorgan
- 01/05/23 Truist
- AbbVie price target raised to $180 from $160 at Truist
- 11/17/22 Credit Suisse
- AbbVie initiated with an Outperform at Credit Suisse
- 01/30/23 Deutsche Bank
- Kellogg price target lowered to $72 from $74 at Deutsche Bank
- 12/20/22 Morgan Stanley
- Kellogg price target raised to $74 from $72 at Morgan Stanley
- 11/15/22 Exane BNP Paribas
- Kellogg initiated with an Underperform at Exane BNP Paribas
- 08/08/22 RBC Capital
- Kellogg price target raised to $70 from $66 at RBC Capital
- 01/26/23 Citi
- Novartis downgraded to Neutral from Buy at Citi
- 01/18/23 Berenberg
- AstraZeneca price target raised to 126 GBp from 118 GBp at Berenberg
- 01/12/23 Guggenheim
- Arvinas downgraded to Neutral at Guggenheim on rising ARV-471 risks
- 01/12/23 Barclays
- CinCor Pharma downgraded to Equal Weight from Overweight at Barclays
- $18.42 /
-2.065 (-10.08%) - 02/09/23 DA Davidson
- Mattel price target lowered to $23 from $31 at DA Davidson
- 01/31/23 Goldman Sachs
- Mattel assumed with a Buy at Goldman Sachs
- 10/26/22 DA Davidson
- Mattel price target lowered to $31 from $45 at DA Davidson
- 10/13/22 Jefferies
- Mattel price target lowered to $22, transferred with a Hold at Jefferies
- 01/31/23
- Exxon Mobil reports Q4 adjusted EPS $3.40, consensus $3.29
- 01/30/23
- Notable companies reporting before tomorrow's open
- 10/28/22
- Exxon Mobil reports Q3 adjusted EPS $4.45, consensus $3.79
- 02/09/23
- Veru reports Q1 EPS (46c), consensus (38c)
- 12/05/22
- Veru reports Q4 EPS (51c), consensus (30c)
- 08/11/22
- Veru reports Q3 EPS (28c), consensus (18c)
- 02/09/23
- Tapestry raises FY23 EPS view to $3.70-$3.75 from $3.60-$3.70, consensus $3.65
- 02/09/23
- Tapestry reports Q2 EPS $1.36, consensus $1.27
- $21.04 /
+3.185 (+17.84%) - 02/08/23
- Sonos affirms FY23 revenue view of $1.7B-$1.8B, consensus $1.73B
- 02/08/23
- Sonos reports Q1 EPS 79c, consensus 40c
- 11/16/22
- Sonos sees FY23 revenue $1.7B-$1.8B, consensus $1.72B
- 11/16/22
- Sonos reports Q4 adjusted EPS (32c), consensus (41c)
- 12/14/22
- J.M. Smucker backs FY23 adjusted EPS view $8.35 -$8.75, consensus $8.60
- 11/21/22
- J.M. Smucker raises FY23 adjusted EPS view to $8.35-$8.75 from $8.20-$8.60
- 11/21/22
- J.M. Smucker reports Q2 adjusted EPS $2.40, consensus $2.19
- 08/23/22
- J.M. Smucker raises FY23 adjusted EPS view to $8.20-$8.60 from $7.85-$8.25
- 02/08/23
- Rapid7 guides initial FY23 EPS 81c-88c, consensus 49c
- 02/08/23
- Rapid7 sees Q1 EPS 7c-10c, consensus 7c
- 02/08/23
- Rapid7 reports Q4 EPS 35c, consensus 18c
- 11/02/22
- Rapid7 sees FY22 EPS 17c-20c, consensus 11c
- 01/30/23
- Purple Innovation sees FY22 net loss ($97.5M)-($83.7M)
- 11/09/22
- Purple Innovation backs FY22 revenue view $570M-$590M, consensus $578.66M
- 11/09/22
- Purple Innovation reports Q3 adjusted EPS 3c, consensus (5c)
- 08/09/22
- Purple Innovation lowers 2022 sales outlook to $570M-$590M from $650M-$690M
- 02/02/23
- Post Holdings reports Q1 EPS $1.52, consensus 68c
- 11/17/22
- Post Holdings reports Q4 adjusted EPS 85c, consensus 70c
- 02/09/23
- PepsiCo sees FY23 core EPS $7.20, consensus $7.28
- 02/09/23
- PepsiCo sees FY23 core EPS growth 8%, consensus $7.28
- 02/09/23
- PepsiCo reports Q4 core EPS $1.67, consensus $1.65
- 02/08/23
- Notable companies reporting before tomorrow's open
- 02/08/23
- New York Times reports Q4 adjusted EPS 59c, consensus 43c
- 11/02/22
- New York Times reports Q3 adjusted EPS 21c, consensus 13c
- 02/09/23
- NuVasive sees FY23 net sales growth 6%-8%, consensus $1.28B
- 02/09/23
- NuVasive sees FY22 net sales growth 5.5%, consensus $1.21B
- 11/09/22
- NuVasive lowers FY22 non-GAAP EPS to $2.00-$2.10 from $2.15-$2.45
- 11/09/22
- NuVasive reports Q3 non-GAAP EPS 54c, consensus 54c
- 02/08/23
- 23andMe sees FY23 revenue $290M-$300M, consensus $276.59M
- 02/08/23
- 23andMe reports Q3 EPS (20c), consensus (19c)
- 11/07/22
- 23andMe sees FY23 revenue $260M-$280M, consensus $277.86M
- 11/07/22
- 23andMe reports Q2 EPS (15c), consensus (17c)
- 11/22/22
- Medtronic sees Q3 adjusted EPS $1.25-$1.27, consensus $1.40
- 11/22/22
- Medtronic says guidance assumes 2H23 reported revenue $15.4B-$15.6B
- 11/22/22
- Medtronic cuts FY23 EPS view to $5.25-$5.30 from $5.53-$5.65, consensus $5.53
- 11/22/22
- Medtronic reports Q2 EPS $1.30, consensus $1.28
- $18.42 /
-2.065 (-10.08%) - 02/08/23
- Mattel sees FY23 adjusted EPS $1.10-$1.20, consensus $1.66
- 02/08/23
- Mattel reports Q4 adjusted EPS 18c, consensus 29c
- 10/25/22
- Mattel cuts FY22 EPS view to $1.32-$1.42 from $1.42-$1.48
- 01/26/23
- Southwest sees Q1 revenue up 20%-24%, consensus $5.88B
- 01/26/23
- Southwest reports Q4 adjusted EPS (38c), consensus (9c)
- 01/25/23
- Notable companies reporting before tomorrow's open
- 02/09/23
- Kellogg sees FY23 EPS down 4% to down 2% on currency neutral basis
- 02/09/23
- Kellogg reports Q4 adjusted currency-neutral EPS 97c, consensus 84c
- 11/07/22
- Hims & Hers raises FY22 revenue view $519M-$522M from $470M-$485M
- 11/07/22
- Hims & Hers sees Q4 revenue $159M-$162M, consensus $134.3M
- 11/07/22
- Hims & Hers reports Q3 EPS (9c), consensus (10c)
- $63.41 /
-13.71 (-17.78%) - 02/09/23
- Globus Medical sees FY23 net sales growth 7%-8%, consensus $1.12B
- 02/09/23
- Globus Medical sees FY22 net sales growth 6.8%, consensus $1.03B
- 11/08/22
- Globus Medical sees FY22 EPS $2.03-$2.10, consensus $2.10
- 11/08/22
- Globus Medical reports Q3 EPS 50c, consensus 52c
- 11/04/22
- DraftKings sees 2023 revenue $2.8B-$3B, consensus $2.83B
- 11/04/22
- DraftKings raises 2022 revenue view $2.16B-$2.19B from $2.08B-$2.18B
- 11/04/22
- DraftKings reports Q3 revenue $502M, consensus $437.23M
- 11/03/22
- Notable companies reporting before tomorrow's open
- $113.43 /
+1.655 (+1.48%) - 02/08/23
- Disney reports Q1 EPS ex-items 99c, consensus 78c
- 02/08/23
- Notable companies reporting after market close
- 11/08/22
- Disney CFO sees FY23 cash content spend in low-$30B range
- 11/08/22
- Disney reports Q4 EPS ex-items 30c, consensus 57c
- $10.25 /
+1.105 (+12.08%) - 02/08/23
- DHT Holdings reports Q4 EPS 38c, consensus 30c
- 11/07/22
- DHT Holdings reports Q3 EPS 4c, consensus (1c)
- 08/10/22
- DHT Holdings reports Q2 EPS 6c, consensus (4c)
CSII Cardiovascular Systems - 02/08/23
- Cardiovascular Systems reports Q2 EPS (20c), consensus (15c)
- 11/03/22
- Cardiovascular Systems sees FY22 revenue $255M-$265M, consensus $258.48M
- 11/03/22
- Cardiovascular Systems reports Q1 EPS (27c), consensus (23c)
- 11/30/22
- Salesforce raises FY23 EPS view to $4.92-$4.94, consensus $4.73
- 11/30/22
- Salesforce sees Q4 EPS $1.35-$1.37, consensus $1.34
- 11/30/22
- Salesforce reports Q3 EPS $1.40, consensus $1.21
- 11/30/22
- Notable companies reporting after market close
- 02/09/23
- AstraZeneca sees FY23 core EPS up high single to low double-digit percentage
- 02/09/23
- AstraZeneca reports Q4 core EPS $1.38, consensus $1.35
- 11/10/22
- AstraZeneca raises FY22 core EPS view to high 20s to low 30s percentage
- 11/10/22
- AstraZeneca reports Q3 core EPS $1.67, YTD core EPS $5.28
- 02/08/23
- Digital Turbine sees FY23 adjusted EPS $1.15-$1.20, consensus $1.41
- 02/08/23
- Digital Turbine reports Q3 adjusted EPS 29c, consensus 37c
- 11/09/22
- Digital Turbine sees Q3 adjusted EPS 36c-39c, consensus 38c
- 11/09/22
- Digital Turbine reports Q2 non-GAAP EPS 34c, consensus 33c
- $16.31 /
+3.625 (+28.58%) - 02/08/23
- AppLovin sees Q1 revenue $685M-$705M, consensus $682.2M
- 02/08/23
- AppLovin reports Q4 adjusted EBITDA up 17% at $260M
- 11/09/22
- AppLovin cuts FY22 revenue view from $2.84B-$3.14B to $2.80B-$2.81B
- 01/09/23
- Accolade guides initial FY24 revenue around $410M, consensus $405.4M
- 01/09/23
- Accolade narrows FY23 revenue view to $361M-$365M, consensus $359.2M
- 01/09/23
- Accolade sees Q4 revenue $97M-$101M, consensus $101.7M
- 01/09/23
- Accolade reports Q3 EPS (56c), consensus (62c)
- $109.77 /
-0.465 (-0.42%) - 01/25/23
- Abbott sees FY23 adjusted EPS $4.30-$4.50, consensus $4.40
- 01/25/23
- Abbott reports Q4 adjusted EPS $1.03, consensus 92c
- 01/24/23
- Notable companies reporting before tomorrow's open
- 02/09/23
- AbbVie sees Q1 adjusted EPS $2.39-$2.49, consensus $3.08
- 02/09/23
- AbbVie sees FY23 revenue about $52B, consensus $54.21B
- 02/09/23
- AbbVie sees FY23 adjusted EPS $10.70-$11.10, consensus $11.65
- 02/09/23
- AbbVie reports Q4 adjusted EPS $3.60, consensus $3.56
- 02/08/23
- AllianceBernstein reports Q4 adjusted EPS 70c, consensus 57c
- 10/28/22
- AllianceBernstein reports Q3 adjusted EPS 64c, consensus 57c
- $153.00 /
+1.055 (+0.69%) - 02/02/23
- Apple reports Q1 EPS $1.88, consensus $1.94
- 02/02/23
- Notable companies reporting after market close
- 10/27/22
- Apple reports Q4 EPS $1.29, consensus $1.17
- 10/27/22
- Notable companies reporting after market close
|
|
Hot Stocks
|
Post Holdings announced… Post Holdings announced it has signed a definitive agreement in which Post will acquire select pet food brands from The J.M. Smucker Co. for $1.2B. The transaction includes leading dog and cat food brands such as Rachael Ray Nutrish, Nature's Recipe, 9Lives, Kibbles 'n Bits and Gravy Train, which together generated net sales of $1.4B in the year ended April 30. Post also is acquiring manufacturing and distribution facilities in Bloomsburg, Pennsylvania and manufacturing facilities in Meadville, Pennsylvania and Lawrence, Kansas. The acquisition will provide Post with a compelling entry point into the attractive and growing pet food category. Post is acquiring an established, scaled position in the mainstream and entry premium sub-categories. Post management expects there to be additional opportunities for future investments in the pet food category. ShowHide Related Items >><< - 01/30/23
- Simply Good Foods says Geoff Tanner, named COO, CEO-elect of company
- 11/21/22
- J.M. Smucker CEO says 'organic top-line growth across all of our businesses'
- 09/14/22
- J.M. Smucker names Amy Held chief transformation officer
- 02/08/23
- J.M. Smucker to sell several pet food brands to Post Holdings for $1.2B
- 02/02/23
- Post Holdings raises FY23 adjusted EBITDA view to $1.025B-$1.065B
- 11/22/22
- Post Holdings to exit ownership of BellRing Brands
- 11/16/22
- Post Holdings promotes Matt Mainer to CFO, Jeff Zadoks to COO
- 02/07/23 Barclays
- Post Holdings price target raised to $105 from $102 at Barclays
- 02/06/23 Truist
- Post Holdings price target raised to $85 from $70 at Truist
- 01/06/23 Evercore ISI
- Hershey downgraded to In Line from Outperform at Evercore ISI
- 11/29/22 Piper Sandler
- Post Holdings price target raised to $115 from $107 at Piper Sandler
- 12/20/22 Morgan Stanley
- J.M. Smucker upgraded to Equal Weight at Morgan Stanley on defensive positioning
- 12/20/22 Morgan Stanley
- J.M. Smucker upgraded to Equal Weight from Underweight at Morgan Stanley
- 12/15/22 Stifel
- J.M. Smucker price target raised to $155 from $148 at Stifel
- 12/15/22 Credit Suisse
- J.M. Smucker price target raised to $165 from $145 at Credit Suisse
- 12/14/22
- J.M. Smucker backs FY23 adjusted EPS view $8.35 -$8.75, consensus $8.60
- 11/21/22
- J.M. Smucker raises FY23 adjusted EPS view to $8.35-$8.75 from $8.20-$8.60
- 11/21/22
- J.M. Smucker reports Q2 adjusted EPS $2.40, consensus $2.19
- 08/23/22
- J.M. Smucker raises FY23 adjusted EPS view to $8.20-$8.60 from $7.85-$8.25
- 02/02/23
- Post Holdings reports Q1 EPS $1.52, consensus 68c
- 11/17/22
- Post Holdings reports Q4 adjusted EPS 85c, consensus 70c
- 12/20/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/21/22
- What You Missed On Wall Street On Monday
- 11/21/22
- What You Missed On Wall Street This Morning
- 11/15/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
|
|
Hot Stocks
|
The J.M. Smucker Co.… The J.M. Smucker Co. (SJM) announced it has entered into a definitive agreement to sell several pet food brands to Post Holdings (POST) headquartered in St. Louis, Missouri. The transaction is valued at approximately $1.2B, consisting of $700M in cash and approximately 5.39M shares of common stock of Post Holdings. The transaction includes the Rachael Ray Nutrish, 9Lives, Kibbles 'n Bits, Nature's Recipe, and Gravy Train brands as well as the company's private label pet food business. The transaction includes relevant trademarks and licenses, and the company's manufacturing and distribution facilities in Bloomsburg, Pennsylvania, as well as its manufacturing facilities in Meadville, Pennsylvania and Lawrence, Kansas. In addition, a group of employees will transition to Post Holdings, Inc. to support the business. The company expects these brands to generate net sales of approximately $1.5B for the fiscal year ended April 30, which are primarily reported in the U.S. Retail Pet Foods segment. The Company expects the divestiture to be dilutive to its adjusted earnings per share by approximately 45c on a full-year basis, reflecting the foregone profit related to the divested brands and before factoring in any benefits from the use of transaction proceeds and the impact of stranded overhead costs. The company anticipates replacing the divested earnings through the deployment of transaction proceeds and mitigating the impact of stranded overhead costs through initiatives within its Transformation Office over time. The transaction is anticipated to close in the fourth quarter of the company's current fiscal year ending April 30, subject to closing conditions including the receipt of required regulatory approvals. ShowHide Related Items >><< - 01/30/23
- Simply Good Foods says Geoff Tanner, named COO, CEO-elect of company
- 11/21/22
- J.M. Smucker CEO says 'organic top-line growth across all of our businesses'
- 09/14/22
- J.M. Smucker names Amy Held chief transformation officer
- 09/09/22
- J.M. Smucker releases 2022 Corporate Impact Report
- 02/02/23
- Post Holdings raises FY23 adjusted EBITDA view to $1.025B-$1.065B
- 11/22/22
- Post Holdings to exit ownership of BellRing Brands
- 11/16/22
- Post Holdings promotes Matt Mainer to CFO, Jeff Zadoks to COO
- 09/06/22
- Post Holdings approves new $300M share repurchase program
- 12/20/22 Morgan Stanley
- J.M. Smucker upgraded to Equal Weight at Morgan Stanley on defensive positioning
- 12/20/22 Morgan Stanley
- J.M. Smucker upgraded to Equal Weight from Underweight at Morgan Stanley
- 12/15/22 Stifel
- J.M. Smucker price target raised to $155 from $148 at Stifel
- 12/15/22 Credit Suisse
- J.M. Smucker price target raised to $165 from $145 at Credit Suisse
- 02/07/23 Barclays
- Post Holdings price target raised to $105 from $102 at Barclays
- 02/06/23 Truist
- Post Holdings price target raised to $85 from $70 at Truist
- 01/06/23 Evercore ISI
- Hershey downgraded to In Line from Outperform at Evercore ISI
- 11/29/22 Piper Sandler
- Post Holdings price target raised to $115 from $107 at Piper Sandler
- 12/14/22
- J.M. Smucker backs FY23 adjusted EPS view $8.35 -$8.75, consensus $8.60
- 11/21/22
- J.M. Smucker raises FY23 adjusted EPS view to $8.35-$8.75 from $8.20-$8.60
- 11/21/22
- J.M. Smucker reports Q2 adjusted EPS $2.40, consensus $2.19
- 08/23/22
- J.M. Smucker raises FY23 adjusted EPS view to $8.20-$8.60 from $7.85-$8.25
- 02/02/23
- Post Holdings reports Q1 EPS $1.52, consensus 68c
- 11/17/22
- Post Holdings reports Q4 adjusted EPS 85c, consensus 70c
- 12/20/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/21/22
- What You Missed On Wall Street On Monday
- 11/21/22
- What You Missed On Wall Street This Morning
- 11/15/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
|
|
Recommendations
|
Barclays analyst Andrew… Barclays analyst Andrew Lazar raised the firm's price target on Post Holdings to $105 from $102 and keeps an Overweight rating on the shares. The analyst continue to believe the stock's nearly 20% valuation discount to peers is "too steep." ShowHide Related Items >><< - 02/02/23
- Post Holdings raises FY23 adjusted EBITDA view to $1.025B-$1.065B
- 11/22/22
- Post Holdings to exit ownership of BellRing Brands
- 11/16/22
- Post Holdings promotes Matt Mainer to CFO, Jeff Zadoks to COO
- 09/06/22
- Post Holdings approves new $300M share repurchase program
- 02/06/23 Truist
- Post Holdings price target raised to $85 from $70 at Truist
- 01/06/23 Evercore ISI
- Hershey downgraded to In Line from Outperform at Evercore ISI
- 11/29/22 Piper Sandler
- Post Holdings price target raised to $115 from $107 at Piper Sandler
- 11/21/22 BMO Capital
- Post Holdings price target raised to $99 from $96 at BMO Capital
- 02/02/23
- Post Holdings reports Q1 EPS $1.52, consensus 68c
- 11/17/22
- Post Holdings reports Q4 adjusted EPS 85c, consensus 70c
|
|
Recommendations
|
Truist analyst Bill… Truist analyst Bill Chappell raised the firm's price target on Post Holdings to $85 from $70 but keeps a Hold rating on the shares. The analyst notes the company's Q1 earnings beat and guidance raise but also prefers to "err on the side of caution", warning that the boost gained in the foodservice business may provide challenging comps for Post Holdings. The firm further notes the potential overhang from the recent avian flu outbreak on the company's egg business and also warns that as consumers adjust to the new "normal", volume of center-store packaged goods may be impacted. ShowHide Related Items >><< - 02/02/23
- Post Holdings raises FY23 adjusted EBITDA view to $1.025B-$1.065B
- 11/22/22
- Post Holdings to exit ownership of BellRing Brands
- 11/16/22
- Post Holdings promotes Matt Mainer to CFO, Jeff Zadoks to COO
- 09/06/22
- Post Holdings approves new $300M share repurchase program
- 01/06/23 Evercore ISI
- Hershey downgraded to In Line from Outperform at Evercore ISI
- 11/29/22 Piper Sandler
- Post Holdings price target raised to $115 from $107 at Piper Sandler
- 11/21/22 BMO Capital
- Post Holdings price target raised to $99 from $96 at BMO Capital
- 08/09/22 Piper Sandler
- Post Holdings price target raised to $100 from $96 at Piper Sandler
- 02/02/23
- Post Holdings reports Q1 EPS $1.52, consensus 68c
- 11/17/22
- Post Holdings reports Q4 adjusted EPS 85c, consensus 70c
|
|
Hot Stocks
|
Prior guidance was… Prior guidance was $990M-$1.04B. Post management now expects FY23 capital expenditures to range between $275M-$300M. ShowHide Related Items >><< - 11/22/22
- Post Holdings to exit ownership of BellRing Brands
- 11/16/22
- Post Holdings promotes Matt Mainer to CFO, Jeff Zadoks to COO
- 09/06/22
- Post Holdings approves new $300M share repurchase program
- 08/09/22
- Post Holdings announces debt-for-equity exchange, offering of BellRing stock
- 01/06/23 Evercore ISI
- Hershey downgraded to In Line from Outperform at Evercore ISI
- 11/29/22 Piper Sandler
- Post Holdings price target raised to $115 from $107 at Piper Sandler
- 11/21/22 BMO Capital
- Post Holdings price target raised to $99 from $96 at BMO Capital
- 08/09/22 Piper Sandler
- Post Holdings price target raised to $100 from $96 at Piper Sandler
- 02/02/23
- Post Holdings reports Q1 EPS $1.52, consensus 68c
- 11/17/22
- Post Holdings reports Q4 adjusted EPS 85c, consensus 70c
|
